These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 20635761)
1. "Tenecteplase--the best among the equals.". Saran RK; Sethi R; Nagori M Indian Heart J; 2009; 61(5):454-8. PubMed ID: 20635761 [TBL] [Abstract][Full Text] [Related]
2. Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction. Melandri G; Vagnarelli F; Calabrese D; Semprini F; Nanni S; Branzi A Vasc Health Risk Manag; 2009; 5(1):249-56. PubMed ID: 19436656 [TBL] [Abstract][Full Text] [Related]
3. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial. ADVANCE MI Investigators Am Heart J; 2005 Jul; 150(1):116-22. PubMed ID: 16084157 [TBL] [Abstract][Full Text] [Related]
5. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction. Dunn CJ; Goa KL Am J Cardiovasc Drugs; 2001; 1(1):51-66. PubMed ID: 14728052 [TBL] [Abstract][Full Text] [Related]
6. Tenecteplase: new preparation. Another thrombolytic agent for myocardial infarction: a slightly simpler treatment. Prescrire Int; 2002 Jun; 11(59):83-4. PubMed ID: 12068843 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Tanswell P; Modi N; Combs D; Danays T Clin Pharmacokinet; 2002; 41(15):1229-45. PubMed ID: 12452736 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Wallentin L; Goldstein P; Armstrong PW; Granger CB; Adgey AA; Arntz HR; Bogaerts K; Danays T; Lindahl B; Mäkijärvi M; Verheugt F; Van de Werf F Circulation; 2003 Jul; 108(2):135-42. PubMed ID: 12847070 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of tenecteplase in acute myocardial infarction. Guerra DR; Karha J; Gibson CM Expert Opin Pharmacother; 2003 May; 4(5):791-8. PubMed ID: 12740001 [TBL] [Abstract][Full Text] [Related]
12. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis. Giraldez RR; Wiviott SD; Nicolau JC; Mohanavelu S; Morrow DA; Antman EM; Giugliano RP Drugs; 2009 Jul; 69(11):1433-43. PubMed ID: 19634922 [TBL] [Abstract][Full Text] [Related]
13. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials. Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698 [TBL] [Abstract][Full Text] [Related]
14. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI. Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980 [TBL] [Abstract][Full Text] [Related]
15. The place of tenecteplase in management of STEMI. Chopra HK Indian Heart J; 2009; 61(5):408-9. PubMed ID: 20635752 [No Abstract] [Full Text] [Related]
16. Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial. Kanakakis J; Nanas JN; Tsagalou EP; Maroulidis GD; Drakos SG; Ntalianis AS; Tzoumele P; Skoumbourdis E; Charbis P; Rokas S; Anastasiou-Nana M Catheter Cardiovasc Interv; 2009 Sep; 74(3):398-405. PubMed ID: 19360864 [TBL] [Abstract][Full Text] [Related]
17. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators Lancet; 2006 Feb; 367(9510):569-78. PubMed ID: 16488800 [TBL] [Abstract][Full Text] [Related]
18. Tenecteplase in the treatment of acute myocardial infarction. Chandra KS; Jariwala P; Lathi P Indian Heart J; 2009; 61(5):437-42. PubMed ID: 20635758 [No Abstract] [Full Text] [Related]